Literature DB >> 33307849

Hypertension, Prehypertension, and Hypertension Control: Association With Decline in Cognitive Performance in the ELSA-Brasil Cohort.

Sara Teles de Menezes1, Luana Giatti1, Luisa Campos Caldeira Brant1, Rosane Harter Griep2, Maria Inês Schmidt3, Bruce Bartholow Duncan3, Claudia Kimie Suemoto4, Antonio Luiz Pinho Ribeiro5, Sandhi Maria Barreto1.   

Abstract

Hypertension, particularly in middle age, has been associated with worse cognitive function, but evidence is inconclusive. This study investigated whether hypertension, prehypertension, age, and duration of diagnosis, as well as blood pressure control, are associated with a decline in cognitive performance in ELSA-Brasil participants. This longitudinal study included 7063 participants, mean age 58.9 years at baseline (2008-2010), who attended visit 2 (2012-2014). Cognitive performance was measured in both visits and evaluated by the standardized scores of the memory, verbal fluency, trail B tests, and global cognitive score. The associations were investigated using linear mixed models. Hypertension and prehypertension at baseline were associated with decline in global cognitive score; being hypertension associated with reduction in memory test; and prehypertension with reduction in fluency test. Hypertension diagnose ≥55 years was associated with lower global cognitive and memory test scores, and hypertension diagnose <55 years with lower memory test scores. Duration of hypertension diagnoses was not associated with any marker of cognitive function decline. Among treated individuals, blood pressure control at baseline was inversely associated with the decline in both global cognitive and memory test scores. In this relatively young cohort, hypertension, prehypertension, and blood pressure control were independent predictors of cognitive decline in distinct abilities. Our findings suggest that both lower and older age of hypertension, but not duration of diagnosis, were associated with cognitive decline in different abilities. In addition to hypertension, prehypertension and pressure control might be critical for the preservation of cognitive function.

Entities:  

Keywords:  association; blood pressure; cognition; diagnosis; memory

Year:  2020        PMID: 33307849     DOI: 10.1161/HYPERTENSIONAHA.120.16080

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

1.  Cardiovascular Statistics - Brazil 2021.

Authors:  Gláucia Maria Moraes de Oliveira; Luisa Campos Caldeira Brant; Carisi Anne Polanczyk; Deborah Carvalho Malta; Andreia Biolo; Bruno Ramos Nascimento; Maria de Fatima Marinho de Souza; Andrea Rocha De Lorenzo; Antonio Aurélio de Paiva Fagundes Júnior; Beatriz D Schaan; Fábio Morato de Castilho; Fernando Henpin Yue Cesena; Gabriel Porto Soares; Gesner Francisco Xavier Junior; Jose Augusto Soares Barreto Filho; Luiz Guilherme Passaglia; Marcelo Martins Pinto Filho; M Julia Machline-Carrion; Marcio Sommer Bittencourt; Octavio M Pontes Neto; Paolo Blanco Villela; Renato Azeredo Teixeira; Roney Orismar Sampaio; Thomaz A Gaziano; Pablo Perel; Gregory A Roth; Antonio Luiz Pinho Ribeiro
Journal:  Arq Bras Cardiol       Date:  2022-01       Impact factor: 2.000

Review 2.  Effects of Hypertension on Alzheimer's Disease and Related Disorders.

Authors:  Joseph E Malone; Mohamed I Elkasaby; Alan J Lerner
Journal:  Curr Hypertens Rep       Date:  2022-09-20       Impact factor: 4.592

3.  Lack of association between proton pump inhibitor use and decline in cognitive performance in the ELSA-Brasil cohort.

Authors:  Andrêza Soares Dos Santos; Sara Teles de Menezes; Isabela M Bensenor; Alessandra Carvalho Goulart; Sandhi Maria Barreto; Roberta Carvalho Figueiredo
Journal:  Eur J Clin Pharmacol       Date:  2021-05-20       Impact factor: 2.953

4.  Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort study.

Authors:  Chi-Hung Liu; Pi-Shan Sung; Yan-Rong Li; Wen-Kuan Huang; Tay-Wey Lee; Chin-Chang Huang; Tsong-Hai Lee; Tien-Hsing Chen; Yi-Chia Wei
Journal:  PLoS Med       Date:  2021-07-19       Impact factor: 11.069

5.  The Association Between the Duration, Treatment, Control of Hypertension and Lifestyle Risk Factors in Middle-Aged and Elderly Patients with Mild Cognitive Impairment: A Case-Control Study.

Authors:  Xiwu Yan; Ting Meng; Huaijun Liu; Jinfeng Liu; Juan Du; Cheng Chang
Journal:  Neuropsychiatr Dis Treat       Date:  2022-03-19       Impact factor: 2.570

6.  Global cognitive function correlates with P-wave dispersion in frail hypertensive older adults.

Authors:  Pasquale Mone; Antonella Pansini; Francesco Calabrò; Stefano De Gennaro; Mafalda Esposito; Paolo Rinaldi; Antonio Colin; Fabio Minicucci; Antonio Coppola; Salvatore Frullone; Gaetano Santulli
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-03-01       Impact factor: 2.885

7.  Association between blood pressure control status, visit-to-visit blood pressure variability, and cognitive function in elderly Chinese: A nationwide study.

Authors:  Luxinyi Xu; Ying Yang; Dan Cui
Journal:  Front Public Health       Date:  2022-08-04

8.  Effect of Acupuncture on Blood Pressure and Metabolic Profile Among Patients With Essential Hypertension: Protocol of a Randomized Clinical Trial.

Authors:  Pan Zhang; Yalan Chen; Furong Zhang; Hong Pei; Mingsheng Sun; Yuzhu Qu; Jiyao Chen; Ting Du; Xiaoguo He; Fanrong Liang; Weiguo Jia; Mingxiao Yang
Journal:  Front Cardiovasc Med       Date:  2022-06-21

Review 9.  Hypertension-induced cognitive impairment: from pathophysiology to public health.

Authors:  Zoltan Ungvari; Peter Toth; Stefano Tarantini; Calin I Prodan; Farzaneh Sorond; Bela Merkely; Anna Csiszar
Journal:  Nat Rev Nephrol       Date:  2021-06-14       Impact factor: 42.439

10.  The Association between Blood Pressure Trajectories and Risk of Cardiovascular Diseases among Non-Hypertensive Chinese Population: A Population-Based Cohort Study.

Authors:  Fang Li; Qian Lin; Mingshu Li; Lizhang Chen; Yingjun Li
Journal:  Int J Environ Res Public Health       Date:  2021-03-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.